Vertex Pharmaceuticals Stock Market Value

VRTX Stock  USD 432.76  12.02  2.86%   
Vertex Pharmaceuticals' market value is the price at which a share of Vertex Pharmaceuticals stock trades on a public exchange. It measures the collective expectations of Vertex Pharmaceuticals investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Vertex Pharmaceuticals and determine expected loss or profit from investing in Vertex Pharmaceuticals over a given investment horizon.
Check out Vertex Pharmaceuticals Correlation, Vertex Pharmaceuticals Volatility and Vertex Pharmaceuticals Alpha and Beta module to complement your research on Vertex Pharmaceuticals.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
Symbol

Vertex Pharmaceuticals Valuation

Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.87
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vertex Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vertex Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vertex Pharmaceuticals.
0.00
03/13/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
03/02/2024
0.00
If you would invest  0.00  in Vertex Pharmaceuticals on March 13, 2022 and sell it all today you would earn a total of 0.00 from holding Vertex Pharmaceuticals or generate 0.0% return on investment in Vertex Pharmaceuticals over 720 days. Vertex Pharmaceuticals is related to or competes with Monster Beverage, Cheesecake Factory, Dave Busters, Wynn Resorts, MGP Ingredients, Park Hotels, and National Beverage. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for tr... More

Vertex Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vertex Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vertex Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Vertex Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Vertex Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vertex Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Vertex Pharmaceuticals historical prices to predict the future Vertex Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vertex Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
430.76432.80434.84
Details
Intrinsic
Valuation
LowRealHigh
348.09350.13476.04
Details
31 Analysts
Consensus
LowTargetHigh
353.69388.67431.42
Details
Earnings
Estimates (0)
LowProjected EPSHigh
3.374.044.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceuticals. Your research has to be compared to or analyzed against Vertex Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Vertex Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Vertex Pharmaceuticals.

Vertex Pharmaceuticals Backtested Returns

Vertex Pharmaceuticals appears to be very steady, given 3 months investment horizon. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had 0.18% return per unit of risk over the last 3 months. Our standpoint towards measuring the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-nine technical indicators for Vertex Pharmaceuticals, which you can use to evaluate the future volatility of the company. Please review Vertex Pharmaceuticals' Semi Deviation of 0.9618, risk adjusted performance of 0.1153, and Coefficient Of Variation of 582.93 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vertex Pharmaceuticals holds a performance score of 13. The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vertex Pharmaceuticals will likely underperform. Although it is vital to follow Vertex Pharmaceuticals current price movements, it is good to be conservative about what you can do with the information regarding equity historical returns. Please operates Vertex Pharmaceuticals value at risk, kurtosis, price action indicator, as well as the relationship between the semi variance and rate of daily change to make a quick decision on whether Vertex Pharmaceuticals existing price patterns will revert.

Auto-correlation

    
  0.55  

Modest predictability

Vertex Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Vertex Pharmaceuticals time series from 13th of March 2022 to 8th of March 2023 and 8th of March 2023 to 2nd of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vertex Pharmaceuticals price movement. The serial correlation of 0.55 indicates that about 55.0% of current Vertex Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.55
Spearman Rank Test0.67
Residual Average0.0
Price Variance1332.03

Vertex Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Vertex Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vertex Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Vertex Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Vertex Pharmaceuticals stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Vertex Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vertex Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vertex Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vertex Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Vertex Pharmaceuticals Lagged Returns

When evaluating Vertex Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vertex Pharmaceuticals stock have on its future price. Vertex Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vertex Pharmaceuticals autocorrelation shows the relationship between Vertex Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Vertex Pharmaceuticals.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out Vertex Pharmaceuticals Correlation, Vertex Pharmaceuticals Volatility and Vertex Pharmaceuticals Alpha and Beta module to complement your research on Vertex Pharmaceuticals.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...